‘Extra research are underway to confirm these findings and expand our mechanistic knowledge of the cellular and molecular events that underlie the adverse health effects of exposure to ambient particulate matter.’.. Air pollution is associated with increased cardiac events Even healthy people subjected to ultrafine particulate pollution connected with targeted traffic and fossil-fuel combustion for two hours show changes in cardiovascular rhythm and evidence of clot formation that might herald the prospect of serious cardiac events, regarding to research from the Environmental Protection Agency. The analysis was released in the American Thoracic Society’s American Journal of Respiratory and Vital Care Medicine. ‘We wanted to consider the specific effects these ultrafine contaminants have on healthy people as these particles are deposited more deeply and with greater efficiency in to the lower respiratory system and may have effects beyond the pulmonary program,’ said lead writer of the scholarly study, James Samet, Ph.D.As Abstract #6, Antiphospholipid Syndrome Clinical Research Task Force Report.
AFFiRiS announces significant progress in collaboration with GSK for Alzheimer’s vaccine development AFFiRiS AG announced today significant improvement in their collaboration with GlaxoSmithKline Biologicals for the development of an active vaccination program against Alzheimer’s disease. While the lead vaccine applicant AD02 happens to be in phase II scientific testing, two additional preclinical programmes successfully have already been completed. The next programme was related to alternative vaccine candidates generated by AFFiRiS’ AFFITOME technology, including candidate AD03. Based on the promising preliminary outcomes of this program, GSK exercised its choice for the choice vaccine applicants which triggered a EUR 2.5 million payment to AFFiRiS.